|
Re: Resverlogix Announces Corporate Update Conference Call...
|
6
|
Resverlogix Corp.
|
Jun 06, 2020 06:31AM
|
|
Re: Resverlogix Announces Extension of Maturity Date of Loan and Expression of Interest Regarding Strategic Transaction
|
7
|
Resverlogix Corp.
|
Aug 28, 2017 07:41PM
|
|
Re: Resverlogix announces HEPALINK debenture $6mill
|
4
|
Resverlogix Corp.
|
May 05, 2021 07:19PM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
5
|
Resverlogix Corp.
|
Apr 19, 2022 05:30PM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
3
|
Resverlogix Corp.
|
Apr 19, 2022 08:35PM
|
|
Re: Resverlogix Announces Presentation at 9th Annual Biotech Showcase Conference in San Francisco, CA
|
2
|
Resverlogix Corp.
|
Jan 06, 2017 03:56PM
|
|
Re: Resverlogix Announces Proposed Offering of Units
|
6
|
Resverlogix Corp.
|
Apr 17, 2018 09:56AM
|
|
Re: Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits
|
5
|
Resverlogix Corp.
|
Jan 11, 2024 08:14AM
|
|
Re: Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits
|
3
|
Resverlogix Corp.
|
Jan 11, 2024 12:18PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
6
|
Resverlogix Corp.
|
Aug 04, 2020 09:09PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
6
|
Resverlogix Corp.
|
Aug 04, 2020 09:21PM
|
|
Re: Resverlogix Announces Upcoming Presentations at Clinical Trials in Alzheimer’s Disease (CTAD) Asia and Alzheimer’s Association International Conferenc
|
2
|
Resverlogix Corp.
|
Jul 17, 2018 11:26AM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
5
|
Resverlogix Corp.
|
Apr 11, 2018 08:06AM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
7
|
Resverlogix Corp.
|
Apr 11, 2018 08:45AM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
5
|
Resverlogix Corp.
|
Apr 11, 2018 09:11AM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
6
|
Resverlogix Corp.
|
Apr 11, 2018 10:24AM
|
|
Re: RESVERLOGIX ANNOUNCES VOTING RESULTS FROM THE 2022 MEETING OF SHAREHOLDERS
|
4
|
Resverlogix Corp.
|
Jun 23, 2022 02:51AM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 07:11PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
4
|
Resverlogix Corp.
|
Nov 25, 2019 07:14PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
9
|
Resverlogix Corp.
|
Mar 27, 2020 11:08AM
|
